Localized tenosynovial giant cell tumor in children.
J Child Orthop 2023;
17:420-427. [PMID:
37799313 PMCID:
PMC10549694 DOI:
10.1177/18632521231186795]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Accepted: 06/01/2023] [Indexed: 10/07/2023] Open
Abstract
Background
To investigate the clinical characteristics and surgical efficacy of localized tenosynovial giant cell tumors in children.
Methods
The clinical data, surgery, and follow-up results of 17 children with localized tenosynovial giant cell tumors who visited our hospital from 2011 to 2021 were collected for statistical analysis.
Results
The median patient age was 7 years and 8 months, and the ratio of males to females was 1.43 (10/7). The predilection of disease was similar in hands and feet, and the common presenting symptom was mass. One patient experienced recurrence after surgery, and one child had postoperative functional limitations.
Conclusion
Extremities are common sites of localized tenosynovial giant cell tumors in children. Complete surgical resection helps reduce the recurrence rate.
Level of evidence
Level III.
Collapse